BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11880159)

  • 1. Identifying disease modifying genes in multiple sclerosis.
    Kantarci OH; de Andrade M; Weinshenker BG
    J Neuroimmunol; 2002 Feb; 123(1-2):144-59. PubMed ID: 11880159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis.
    de la Concha EG; Arroyo R; Crusius JB; Campillo JA; Martin C; Varela de Seijas E; Peña AS; Clavería LE; Fernandez-Arquero M
    J Neuroimmunol; 1997 Dec; 80(1-2):172-8. PubMed ID: 9413274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis.
    Kantarci OH; Atkinson EJ; Hebrink DD; McMurray CT; Weinshenker BG
    J Neuroimmunol; 2000 Jul; 106(1-2):220-7. PubMed ID: 10814801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interleukin 1-receptor-antagonist gene polymorphism is not associated with multiple sclerosis.
    Huang WX; He B; Hillert J
    J Neuroimmunol; 1996 Jul; 67(2):143-4. PubMed ID: 8765338
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity.
    Mann CL; Davies MB; Stevenson VL; Leary SM; Boggild MD; Ko Ko C; Jones PW; Fryer AA; Strange RC; Thompson AJ; Hawkins CP
    J Neuroimmunol; 2002 Aug; 129(1-2):197-204. PubMed ID: 12161036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis.
    Luomala M; Lehtimäki T; Elovaara I; Wang X; Ukkonen M; Mattila K; Laippala P; Koivula T; Hurme M
    J Neurol Sci; 2001 Apr; 185(2):123-7. PubMed ID: 11311293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis.
    Crusius JB; Peña AS; Van Oosten BW; Bioque G; Garcia A; Dijkstra CD; Polman CH
    Lancet; 1995 Oct; 346(8980):979. PubMed ID: 7564774
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.
    Dincić E; Zivković M; Stanković A; Obradović D; Alavantić D; Kostić V; Raicević R
    J Neuroimmunol; 2006 Aug; 177(1-2):146-50. PubMed ID: 16769128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor 2 allele does not contribute to increased tumor necrosis factor-alpha production in Sardinian multiple sclerosis.
    Sotgiu S; Pugliatti M; Serra C; Rosati G; Dolei A; Marrosu MG
    Ann Neurol; 1999 Nov; 46(5):799-800. PubMed ID: 10554002
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of multiple sclerosis-associated genes.
    Hogancamp WE; Rodriguez M; Weinshenker BG
    Mayo Clin Proc; 1997 Oct; 72(10):965-76. PubMed ID: 9379703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
    Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is multiple sclerosis severity a genetically influenced trait?
    Cocco E; Marrosu MG
    Neurol Sci; 2000; 21(4 Suppl 2):S843-7. PubMed ID: 11205360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group.
    Reboul J; Mertens C; Levillayer F; Eichenbaum-Voline S; Vilkoren T; Cournu I; Babron MC; Lyon-Caen O; Clerget-Darpoux F; Edan G; Clanet M; Brahic M; Bureau JF; Fontaine B; Liblau R
    J Neuroimmunol; 2000 Jan; 102(1):107-12. PubMed ID: 10626674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
    Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
    PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
    Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
    Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
    Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis.
    Ma JJ; Nishimura M; Mine H; Saji H; Ohta M; Saida K; Ozawa K; Kawakami H; Saida T; Uchiyama T
    J Neuroimmunol; 1998 Dec; 92(1-2):109-12. PubMed ID: 9916885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis for clinical expression in multiple sclerosis.
    Barcellos LF; Oksenberg JR; Green AJ; Bucher P; Rimmler JB; Schmidt S; Garcia ME; Lincoln RR; Pericak-Vance MA; Haines JL; Hauser SL;
    Brain; 2002 Jan; 125(Pt 1):150-8. PubMed ID: 11834600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interleukin-1 gene family in multiple sclerosis susceptibility and disease course.
    Hooper-van Veen T; Schrijver HM; Zwiers A; Crusius JB; Knol DL; Kalkers NF; Laine ML; Barkhof F; Peña AS; Polman CH; Uitdehaag BM
    Mult Scler; 2003 Dec; 9(6):535-9. PubMed ID: 14664464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.